References
1. Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M,
Fineman S, et al. World allergy organization anaphylaxis guidance 2020.
World Allergy Organ J. 2020;13(10):100472.
2. Bilò MB, Martini M, Tontini C, Corsi A, Antonicelli L. Anaphylaxis.
Eur Ann Allergy Clin Immunol. 2021;53(1):4‑17.
3. Poziomkowska-Gęsicka I, Kostrzewska M, Kurek M. Comorbidities and
Cofactors of Anaphylaxis in Patients with Moderate to Severe
Anaphylaxis. Analysis of Data from the Anaphylaxis Registry for West
Pomerania Province, Poland. Int J Environ Res Public Health.
2021;18(1):E333.
4. Caughey GH. Mast cell proteases as pharmacological targets. Eur J
Pharmacol. 2016;778:44‑55.
5. Gonzalez-Quintela A, Vizcaino L, Gude F, Rey J, Meijide L,
Fernandez-Merino C, et al. Factors influencing serum total tryptase
concentrations in a general adult population. Clin Chem Lab Med.
2010;48(5):701‑6.
6. Fenger RV, Linneberg A, Vidal C, Vizcaino L, Husemoen LL, Aadahl M,
et al. Determinants of serum tryptase in a general population: the
relationship of serum tryptase to obesity and asthma. Int Arch Allergy
Immunol. 2012;157(2):151‑8.
7. Sperr WR, El-Samahi A, Kundi M, Girschikofsky M, Winkler S, Lutz D,
et al. Elevated tryptase levels selectively cluster in myeloid
neoplasms: a novel diagnostic approach and screen marker in clinical
haematology. Eur J Clin Invest. 2009;39(10):914‑23.
8. Aniceto V, Dias MM, Melo JML, Trevisan-Neto O, Aragon DC, Maia LSM,
et al. Serum Baseline Tryptase Level as a Marker for the Severity of
Anaphylaxis. Int Arch Allergy Immunol. 2019;179(3):201‑8.
9. Sahiner UM, Yavuz ST, Buyuktiryaki B, Cavkaytar O, Yilmaz EA, Tuncer
A, et al. Serum basal tryptase may be a good marker for predicting the
risk of anaphylaxis in children with food allergy. Allergy.
2014;69(2):265‑8.
10. Francuzik W, Ruëff F, Bauer A, Bilò MB, Cardona V, Christoff G, et
al. Phenotype and risk factors of venom-induced anaphylaxis:
A case-control study of the European Anaphylaxis Registry. J Allergy
Clin Immunol. 2021;147(2):653-662.e9.
11. Fellinger C, Hemmer W, Wöhrl S, Sesztak-Greinecker G, Jarisch R,
Wantke F. Clinical characteristics and risk profile of patients with
elevated baseline serum tryptase. Allergol Immunopathol (Madr).
2014;42(6):544‑52.
12. Dribin TE, Schnadower D, Wang J, Camargo CA, Michelson KA, Shaker M,
et al. Anaphylaxis knowledge gaps and future research priorities:
A consensus report. J Allergy Clin Immunol. 2021;S0091-6749(21)01209-4.
13. Nomura T, Sekii H, Sugita M, Nakahara S. Association between
biphasic reactions and the systems of symptoms and treatment in patients
with anaphylaxis hospitalized from the emergency department. Acute Med
Surg. déc 2020;7(1):e599.
14. Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of
Onset and Predictors of Biphasic Anaphylactic Reactions: A Systematic
Review and Meta-analysis. J Allergy Clin Immunol Pract.
2015;3(3):408-416.e1-2.
15. Lee S, Peterson A, Lohse CM, Hess EP, Campbell RL. Further
Evaluation of Factors That May Predict Biphasic Reactions in Emergency
Department Anaphylaxis Patients. J Allergy Clin Immunol Pract.
2017;5(5):1295‑301.
16. Grunau BE, Li J, Yi TW, Stenstrom R, Grafstein E, Wiens MO, et al.
Incidence of clinically important biphasic reactions in emergency
department patients with allergic reactions or anaphylaxis. Ann Emerg
Med. 2014;63(6):736-744.e2.
17. Pourmand A, Robinson C, Syed W, Mazer-Amirshahi M. Biphasic
anaphylaxis: A review of the literature and implications for emergency
management. Am J Emerg Med. 2018;36(8):1480‑5.
18. Rohacek M, Edenhofer H, Bircher A, Bingisser R. Biphasic
anaphylactic reactions: occurrence and mortality. Allergy.
2014;69(6):791‑7.
19. Allergy Clin Immunol., éditeur. Late cutaneous allergic responses in
IgE-dependent reactions. In 1973. p. 52: 38-46.
20. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the
immediate wheal and flare skin reaction. Its dependence upon IgE
antibodies. J Clin Invest. 1976;58(2):408‑20.
21. Dribin TE, Schnadower D, Wang J, Camargo CA, Michelson KA, Shaker M,
et al. Anaphylaxis knowledge gaps and future research priorities:
A consensus report. J Allergy Clin Immunol. 2021;S0091-6749(21)01209-4.
22. Brazil E, MacNamara AF. « Not so immediate » hypersensitivity–the
danger of biphasic anaphylactic reactions. J Accid Emerg Med.
1998;15(4):252‑3.
23. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma
Immunol Off Publ Am Coll Allergy Asthma Immunol. 2005;95(3):217‑26; quiz
226, 258.
24. Douglas DM, Sukenick E, Andrade WP, Brown JS. Biphasic systemic
anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol.
1994;93(6):977‑85.
25. Ellis A. Biphasic anaphylaxis: a prospective evaluation of
incidence, characteristics, and predictors. In Kingston; 2002.
26. Lee S, Bellolio MF, Hess EP, Campbell RL. Predictors of biphasic
reactions in the emergency department for patients with anaphylaxis. J
Allergy Clin Immunol Pract. 2014;2(3):281‑7.
27. Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA,
Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update,
systematic review, and Grading of Recommendations, Assessment,
Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol.
2020;145(4):1082‑123.
28. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock SA,
Branum A, et al. Second symposium on the definition and management of
anaphylaxis: Summary report - Second National Institute of Allergy and
Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. Ann
Emerg Med. 2006;47(4):373‑80.
29. Simard D, Bouchard V, Plourde A, Lefebvre S, Herman-Lemelin A,
Lapointe S, et al. Factors influencing emergency department observation
time following anaphylaxis: a systematic review. CJEM.
2021;23(4):480‑93.
30. Lee S, Sadosty AT, Campbell RL. Update on biphasic anaphylaxis. Curr
Opin Allergy Clin Immunol. 2016;16(4):346‑51.
31. Liu X, Lee S, Lohse CM, Hardy CT, Campbell RL. Biphasic Reactions in
Emergency Department Anaphylaxis Patients: A Prospective Cohort Study. J
Allergy Clin Immunol Pract. 2020;8(4):1230‑8.
32. Brady WJ, Luber S, Joyce TP. Multiphasic anaphylaxis: report of a
case with prehospital and emergency department considerations. J Emerg
Med. 1997;15(4):477‑81.
33. Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of
Onset and Predictors of Biphasic Anaphylactic Reactions: A Systematic
Review and Meta-analysis. J Allergy Clin Immunol Pract.
2015;3(3):408-416.e1-2.
34. Ko BS, Kim WY, Ryoo SM, Ahn S, Sohn CH, Seo D-W, et al. Biphasic
reactions in patients with anaphylaxis treated with corticosteroids. Ann
Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol.
2015;115(4):312‑6.
35. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J
Allergy Clin Immunol. 1986;78(1 Pt 1):76‑83.
36. Alqurashi W, Stiell I, Chan K, Neto G, Alsadoon A, Wells G.
Epidemiology and clinical predictors of biphasic reactions in children
with anaphylaxis. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy
Asthma Immunol. 2015;115(3):217-223.e2.
37. Scranton SE, Gonzalez EG, Waibel KH. Incidence and characteristics
of biphasic reactions after allergen immunotherapy. J Allergy Clin
Immunol. 2009;123(2):493‑8.
38. Confino-Cohen R, Goldberg A. Allergen immunotherapy-induced biphasic
systemic reactions: incidence, characteristics, and outcome: a
prospective study. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy
Asthma Immunol. 2010;104(1):73‑8.
39. Brady WJ, Luber S, Joyce TP. Multiphasic anaphylaxis: report of a
case with prehospital and emergency department considerations. J Emerg
Med. 1997;15(4):477‑81.
40. Gülen T, Ljung C, Nilsson G, Akin C. Risk Factor Analysis of
Anaphylactic Reactions in Patients With Systemic Mastocytosis. J Allergy
Clin Immunol Pract. 2017;5(5):1248‑55.
41. Bonadonna P, Zanotti R, Müller U. Mastocytosis and insect venom
allergy. Curr Opin Allergy Clin Immunol. 2010;10(4):347‑53.
42. Kraft M, Scherer Hofmeier K, Ruëff F, Pföhler C, Renaudin J-M, Bilò
MB, et al. Risk Factors and Characteristics of Biphasic Anaphylaxis. J
Allergy Clin Immunol Pract. 2020;8(10):3388-3395.e6.
43. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions
to colloid volume substitutes. Lancet Lond Engl. 1977;1(8009):466‑9.
44. Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A,
Esteban-López MI, Vega A, et al. Clinical, biological, and molecular
characteristics of clonal mast cell disorders presenting with systemic
mast cell activation symptoms. J Allergy Clin Immunol.
2010;125(6):1269-1278.e2.
45. Rakotomalala R. Comparaison de populations. 2008;109.
46. Borovkov A. Mathematical Statistics. MIR. Moscow; 1987.
47. Ellis A. Biphasic anaphylaxis: a prospective evaluation of
incidence, characteristics, and predictors. In Kingston; 2002.
48. Simons FER, Ardusso LR, Bilò MB, Cardona V, Ebisawa M, El-Gamal YM,
et al. International consensus on (ICON) anaphylaxis. World Allergy
Organ J. 2014;7(1):9.
49. González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LAG. Anaphylaxis
epidemiology in patients with and patients without asthma: a United
Kingdom database review. J Allergy Clin Immunol.
2010;125(5):1098-1104.e1.
50. Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M,
Fineman S, et al. World allergy organization anaphylaxis guidance 2020.
World Allergy Organ J. 2020;13(10):100472.
51. Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global Trends in
Anaphylaxis Epidemiology and Clinical Implications. J Allergy Clin
Immunol Pract. 2020;8(4):1169‑76.
52. Balzar S, Fajt ML, Comhair SAA, Erzurum SC, Bleecker E, Busse WW, et
al. Mast cell phenotype, location, and activation in severe asthma. Data
from the Severe Asthma Research Program. Am J Respir Crit Care Med.
2011;183(3):299‑309.
53. Maun HR, Jackman JK, Choy DF, Loyet KM, Staton TL, Jia G, et al. An
Allosteric Anti-tryptase Antibody for the Treatment of Mast
Cell-Mediated Severe Asthma. Cell. 2019;179(2):417-431.e19.
54. Sprinzl B, Greiner G, Uyanik G, Arock M, Haferlach T, Sperr WR, et
al. Genetic Regulation of Tryptase Production and Clinical Impact:
Hereditary Alpha Tryptasemia, Mastocytosis and Beyond. Int J Mol Sci.
2021;22(5):2458.
55. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T,
et al. Increase in anaphylaxis-related hospitalizations but no increase
in fatalities: an analysis of United Kingdom national anaphylaxis data,
1992-2012. J Allergy Clin Immunol. 2015;135(4):956-963.e1.
Table 1. Profile of biphasic reactions